FDA product code · General Hospital · Class 2
NGT: Saline, Vascular Access Flush
NGT is FDA's product code for "Saline, Vascular Access Flush": a Class 2 device classified under 21 CFR 880.5200, reviewed by the General Hospital panel.
510(k) review time for NGT
Across 15 510(k) clearances under NGT decided from 2018-01-01 to 2026-10-06, the median was 145 days from FDA receipt to decision. Half took between 111 and 208 days, and 80% were decided within 216 days. These are past clearances, not a forecast for a new submission.
| Fastest | 28 |
|---|---|
| 25th percentile | 111 |
| Median | 145 |
| 75th percentile | 208 |
| 80th percentile | 216 |
| 90th percentile | 247 |
| Slowest | 254 |
Source: openFDA 510(k) records, snapshot of 2026-10-06 (openFDA data as of 2026-09-28). Compare 510(k) review times across all device types, see every code side by side in the Clearance Timeline Estimator, or browse the clearances themselves in PredicateScope.
NGT in the public FDA record
| 510(k) clearances, all years | 40 |
|---|---|
| Device recalls | 61 |
| Establishment listings | 91 |
Counts of records, not of devices or events. Adverse event reports for NGT are in MAUDEScope, as counts with the query shown: MAUDE has no denominator, so a report count is not a rate and does not show that a device caused an event.
FDA-recognized standards that cite NGT
6 FDA recognized consensus standards cite NGT, among them ISO 18193 First edition 2021-08; ISO 11658 First edition 2012-05-15; ISO 23908 First edition 2011-06-11. Horizontal standards such as biocompatibility, sterilization and software standards can apply without citing the code.
- 3-176 ISO 18193 First edition 2021-08 — Cardiovascular implants and artificial organs - Cannulae for extracorporeal circulation
- 3-183 ISO 11658 First edition 2012-05-15 — Cardiovascular implants and extracorporeal systems - Blood/tissue contact surface modifications for extracorporeal perfusion systems
- 6-273 ISO 23908 First edition 2011-06-11 — Sharps injury protection - Requirements and test methods - Sharps protection features for single-use hypodermic needles introducers for catheters and needles used for blood sampling
- 6-466 USP-NF M76070_03_01 — Sodium Chloride Injection
- 6-499 ISO 10555-1 Third edition 2023-11 — Intravascular catheters - Sterile and single-use intravascular catheters - Part 1: General requirements
- 6-507 ISO 23908 Second Edition 2024-12 — Sharps injury protection - Sharps protection mechanisms for single-use needles introducers for catheters and needles used for blood testing monitoring sampling and medical substance administration - Requirements and test methods
Source: FDA Recognized Consensus Standards, snapshot of 2026-09-01. Search them all in the Consensus Standards Lookup.